Go to:
Logótipo
You are here: Start > Publications > View > Antidepressant Drug Sertraline against Human Cancer Cells
Concurso de Escrita Criativa da FEUP
Publication

Antidepressant Drug Sertraline against Human Cancer Cells

Title
Antidepressant Drug Sertraline against Human Cancer Cells
Type
Another Publication in an International Scientific Journal
Year
2022
Authors
Duarte, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: BiomoleculesImported from Authenticus Search for Journal Publications
Vol. 12
Final page: 1513
ISSN: 2218-273X
Publisher: MDPI
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge - 0 Citations
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-00X-ABK
Abstract (EN): The use of FDA-approved drugs for new indications represents a faster and more economical way to find novel therapeutic agents for cancer therapy, compared to the development of new drugs. Repurposing drugs is advantageous in a pharmacological context since these drugs already have extensive data related to their pharmacokinetics, facilitating their approval process for different diseases. Several studies have reported the promising anticancer effects of sertraline, both alone and combined, in different types of cancer cell lines. Here, we performed a literature review on the anticancer potential of sertraline against different human cancer cells, more specifically in lung, colorectal, breast, hepatocellular, leukemia, brain, skin, oral, ovarian, and prostate cancer. Taken together, these findings suggest that sertraline decreases cell viability, proliferation, migration, and invasion, induces apoptosis, and causes cell cycle arrest in different types of cancer cells, besides being an established P-glycoprotein modulator. It was also found that this drug is able to modulate autophagy, cause DNA fragmentation, and induce radical oxygen species (ROS) formation. Moreover, it was found this drug targets important cellular pathways involved in tumorigeneses such as the TNF-MAP4K4-JNK pathway, the antiapoptotic pathway PI3K/Akt/mTOR, and the AMPK/mTOR axis. This drug also interferes with the TCTP/P53 feedback loop and with the cytosolic free Ca2+ levels. Together, these results suggest that sertraline may be a promising compound for further evaluation in novel cancer therapies.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 23
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Combining repurposed drugs to treat colorectal cancer (2022)
Another Publication in an International Scientific Journal
Duarte, D; Nuno Vale
Target-Oriented Synthesis of Marine Coelenterazine Derivatives with Anticancer Activity by Applying the Heavy-Atom Effect (2021)
Article in International Scientific Journal
Magalhaes, CM; Gonzalez Berdullas, P; Duarte, D; Correia, AS; Rodriguez Borges, JE; Nuno Vale; Joaquim C G E Esteves da Silva; da Silva, LP
Study of the Combination of Self-Activating Photodynamic Therapy and Chemotherapy for Cancer Treatment (2019)
Article in International Scientific Journal
da Silva, LP; Magalhaes, CM; Nunez Montenegro, A; Ferreira, PJO; Duarte, D; Rodriguez Borges, JE; Nuno Vale; Joaquim C G E Esteves da Silva

See all (24)

Of the same journal

The Impact of Flavonoid-Loaded Nanoparticles in the UV Protection and Safety Profile of Topical Sunscreens (2023)
Another Publication in an International Scientific Journal
Fonseca, M; Rehman, M; soares, r; Fonte, P
Stalling the Course of Neurodegenerative Diseases: Could Cyanobacteria Constitute a New Approach toward Therapy? (2023)
Another Publication in an International Scientific Journal
Ramos, V; Reis, M; Ferreira, L; Silva, AM; Ferraz, R; Vieira, M; Vitor Vasconcelos; Martins, R
Saquinavir: From HIV to COVID-19 and Cancer Treatment (2022)
Another Publication in an International Scientific Journal
Pereira, M; Nuno Vale
Natural Sympathomimetic Drugs: From Pharmacology to Toxicology (2022)
Another Publication in an International Scientific Journal
Costa, VM; Grando, LGR; Milandri, E; Nardi, J; Teixeira, P; Mladenka, P; Fernando Remiao
Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems (2020)
Another Publication in an International Scientific Journal
Baldim, I; Oliveira, WP; Kadian, V; Rao, R; Yadav, N; Mahant, S; Lucarini, M; Durazzo, A; Da Ana, R; Capasso, R; Souto, SB; Santini, A; Souto, EB

See all (51)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2024-08-21 at 12:00:13 | Acceptable Use Policy | Data Protection Policy | Complaint Portal